Danske Bank’s AIM ImmunoTech AIM Stock Holding History

Danske Bank’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3	Closed	-$26	–	1579
2025 Q2	$26	Buy	+3	New	+$30	﹤0.01%	1444

Other funds holding AIM

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Danske Bank's AIM Position: Q3 2025 in Review

Danske Bank sold out of AIM ImmunoTech (AIM) in Q3 2025, closing a stake of 3 shares — an estimated $26 sold.

Danske Bank first reported a position in AIM in Q2 2025 and held it in 1 quarter. The position peaked at $26 in Q2 2025. 15 funds tracked by Wall St. Rank hold AIM as of Q3 2025.

Danske Bank reported no remaining AIM ImmunoTech position as of Q3 2025 after selling out during the quarter.
Danske Bank sold 3 AIM ImmunoTech shares in Q3 2025, an estimated $26.
Danske Bank first reported a position in AIM ImmunoTech in Q2 2025 and held it in 1 quarter.
Danske Bank's AIM ImmunoTech position peaked at $26 in Q2 2025.
15 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q3 2025.

Based on Danske Bank's 13F filing for Q3 2025, filed 13 Nov 2025.